Global Infection Control Market, By Product (Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-Microbial Surfaces, Other Infection Control Products), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others) – Industry Trends and Forecast to 2030.
Infection Control Market Analysis and Size
Healthcare-associated infections (HAIs) are one of the top causes of death worldwide, accounting for almost 100,000 deaths in the U.S. alone each year. The patient's immune system, infection control methods, and the presence of numerous infectious agents in the healthcare facility all play a role in disease transmission. Age and longer stays in facilities are also major factors in the development of the infections. Due to the growing need to reduce surgical site infections (ISO), strict sterilisation rules, and the widespread use of sterilisers in various applications such as sterilisation of medical devices, pharmaceutical sterilisation, and sterilisation in the life sciences industry, “sterilisation products” segment of product hold the largest market share and will impact in the overall growth of the global infection control market.
Data Bridge Market Research analyses that the global infection control market which was USD 46.85 million in 2022, is expected to reach USD 68.16 million by 2030, and is expected to undergo a CAGR of 4.8% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Infection Control Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015-2020) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Product (Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-microbial Surfaces, Other Infection Control Products), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others) |
Countries Covered |
U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
3M (U.S.), STERIS. (U.S.), Getinge AB (Sweden), Cantel Medical (U.S.), MATACHANA GROUP (Spain), Ecolab (U.S.), BELIMED, INC (Switzerland), Cardinal Health. (U.S.), Steelco S.p.A. (Italy), Reckitt Benckiser Group plc (UK), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Covalon Technologies Ltd. (Canada), SKYTRON, LLC (U.S.), Olympus Corporation (Japan), COLTENE Group (Switzerland), Pal International (India), MELAG Medizintechnik GmbH & Co. KG (Germany), Cisa Production S.r.l. Unipersonale (Italy), Terragene (UK), The Clorox Company (U.S.) |
Market Opportunities |
|
Market Definition
Viruses, bacteria, fungus, and parasites are the most common causes of infections. Stomach and intestine infections, lung and respiratory infections, eye and ear infections, hospital acquired infections (HAIs), skin infections, and sexually transmitted infections are all examples of infections. Infection control is the process of removing or preventing the spread of contaminants in healthcare settings.
Global Infection Control Market Dynamics
Drivers
- Rise in the Prevalence of Hospital-Acquired Infections (HAIs)
Hospital-acquired infections (HAIs) are nosocomial infections that develop during a patient's stay in a hospital or other healthcare facility and are not detected during admission. They are a leading cause of illness and mortality throughout the world which will further accelerate the market growth.
- Technological Developments in Sterilization Equipment
With advancements in infection control technology, new technologies are being adopted and medical gadget manufacturing that have advanced technologically which is further anticipated to propel the growth of the global infection control market during the forecasted period of 2023 to 2030.
Opportunity
- Rise in the Outsourcing of Sterilization Services
The rise in the outsourcing of sterilization services among hospitals, pharmaceutical and medical device companies, growing in the production of medical nonwovens and single-use products due to surge in cases of COVID-19 are further estimated to provide potential opportunities for the growth of the global infection control market in the forecasted period of 2023 to 2030.
Restraint/Challenge
- Safety and associated related Concerns
The concerns related to the safety of reprocessed instruments and hostile effects of chemical disinfectants is further projected to impede the growth of the global infection control market during the forecasted period of 2023 to 2030. However, the sterilization and disinfection of advanced medical instruments might further challenge the growth of the global infection control market in the near future.
This global infection control market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global infection control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In May, 2020, Getinge AB has introduced faster indicators to improve patient safety. The new Superfast 20 indicators are ISO 11138 compliant and compatible with most types of steam and hydrogen peroxide sterilisers. The company's market share in the worldwide patient safety market will increase as a result of this product introduction
Global Infection Control Market Scope and Market Size
The global infection control market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Sterilization Products
- Cleaning and Disinfection Products
- Personal Protective Barriers
- Endoscope Reprocessing Products
- Anti-Microbial Surfaces
- Other Infection Control Products
Application
- Surgical Instruments
- Endoscopes
- Ultrasound Probes
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Third Party Distributors
End User
- Hospitals
- Clinics
- Medical Device Companies
- Pharmaceutical and Biotechnology Companies
- Laboratories
- Others
Global Infection Control Market Regional Analysis/Insights
The global infection control market is analysed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.
The countries covered in the global infection control market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global infection control market due to the rise in the efforts by the established companies. Furthermore, the steady number of strategic associations adopted by key market players will further boost the growth of the infection control market in the region during the forecast period.
Asia-Pacific is expected to be the fastest growing region in the global infection control market due to the amount of growth during the forecast period of 2023 to 2030, due to the rise in the occurrence of outsourcing organizations. Moreover, the increasing healthcare expenses is further anticipated to propel the growth of the infection control market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global infection control market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global infection control market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global infection control market. The data is available for historic period 2010-2020.
Competitive Landscape and Global Infection Control Market Share Analysis
The global infection control market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global infection control market.
Some of the major players operating in the global infection control market are
- 3M (U.S.)
- STERIS. (U.S.)
- Getinge AB (Sweden)
- Cantel Medical (U.S.)
- MATACHANA GROUP (Spain)
- Ecolab (U.S.)
- BELIMED, INC (Switzerland)
- Cardinal Health. (U.S.)
- Steelco S.p.A. (Italy)
- Reckitt Benckiser Group plc (UK)
- Stryker Corporation (U.S.)
- B. Braun Melsungen AG (Germany)
- Covalon Technologies Ltd. (Canada)
- SKYTRON, LLC (U.S.)
- Olympus Corporation (Japan)
- COLTENE Group (Switzerland)
- Pal International (India)
- MELAG Medizintechnik GmbH & Co. KG (Germany)
- Cisa Production S.r.l. Unipersonale (Italy)
- Terragene (UK)
- The Clorox Company (U.S.)
SKU-